<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'><collection><source>PubTator</source><date></date><key>BioC.key</key><document><id>31105667</id><passage><infon key="journal">Front Microbiol; 20191 10 869. doi:10.3389/fmicb.2019.00869</infon><infon key="year">2019</infon><infon key="article-id_pmc">PMC6491927</infon><infon key="type">title</infon><infon key="authors">Roberts AEL, Powell LC, Pritchard MF, Thomas DW, Jenkins RE, </infon><offset>0</offset><text>Anti-pseudomonad Activity of Manuka Honey and Antibiotics in a Specialized ex vivo Model Simulating Cystic Fibrosis Lung Infection.</text><annotation id="1"><infon key="Identifier">MESH:D003550</infon><infon key="type">Disease</infon><location length="30" offset="100"/><text>Cystic Fibrosis Lung Infection</text></annotation></passage><passage><infon key="type">abstract</infon><offset>132</offset><text>Pseudomonas aeruginosa causes problematic chronic lung infections in those suffering from cystic fibrosis. This is due to its antimicrobial resistance mechanisms and its ability to form robust biofilm communities with increased antimicrobial tolerances. Using novel antimicrobials or repurposing current ones is required in order to overcome these problems. Manuka honey is a natural antimicrobial agent that has been used for many decades in the treatment of chronic surface wounds with great success, particularly those infected with P. aeruginosa. Here we aim to determine whether the antimicrobial activity of manuka honey could potentially be repurposed to inhibit pulmonary P. aeruginosa infections using two ex vivo models. P. aeruginosa isolates (n = 28) from an international panel were tested for their susceptibility to manuka honey and clinically relevant antibiotics (ciprofloxacin, ceftazidime, and tobramycin), alone and in combination, using conventional antimicrobial susceptibility testing (AST). To increase clinical applicability, two ex vivo porcine lung (EVPL) models (using alveolar and bronchiolar tissue) were used to determine the anti-biofilm effects of manuka honey alone and in combination with antibiotics. All P. aeruginosa isolates were susceptible to manuka honey, however, varying incidences of resistance were seen against antibiotics. The combination of sub-inhibitory manuka honey and antibiotics using conventional AST had no effect on activity against the majority of isolates tested. Using the two ex vivo models, 64% (w/v) manuka honey inhibited many of the isolates where abnormally high concentrations of antibiotics could not. Typically, combinations of both manuka honey and antibiotics had increased antimicrobial activity. These results highlight the potential of manuka honey as a future antimicrobial for the treatment of pulmonary P. aeruginosa isolates, clearing potential infection reservoirs within the upper airway.</text><annotation id="13"><infon key="Identifier">MESH:D055370</infon><infon key="type">Disease</infon><location length="53" offset="144"/><text>aeruginosa causes problematic chronic lung infections</text></annotation><annotation id="14"><infon key="Identifier">MESH:D003550</infon><infon key="type">Disease</infon><location length="15" offset="222"/><text>cystic fibrosis</text></annotation><annotation id="15"><infon key="identifier">287</infon><infon key="type">Species</infon><location length="13" offset="668"/><text>P. aeruginosa</text></annotation><annotation id="16"><infon key="Identifier">MESH:D007239</infon><infon key="type">Disease</infon><location length="21" offset="815"/><text>aeruginosa infections</text></annotation><annotation id="17"><infon key="identifier">287</infon><infon key="type">Species</infon><location length="13" offset="863"/><text>P. aeruginosa</text></annotation><annotation id="18"><infon key="Identifier">MESH:D002939</infon><infon key="type">Chemical</infon><location length="13" offset="1013"/><text>ciprofloxacin</text></annotation><annotation id="19"><infon key="Identifier">MESH:D002442</infon><infon key="type">Chemical</infon><location length="11" offset="1028"/><text>ceftazidime</text></annotation><annotation id="20"><infon key="Identifier">MESH:D014031</infon><infon key="type">Chemical</infon><location length="10" offset="1045"/><text>tobramycin</text></annotation><annotation id="21"><infon key="Identifier">MESH:C565377</infon><infon key="type">Disease</infon><location length="19" offset="1376"/><text>aeruginosa isolates</text></annotation><annotation id="22"><infon key="Identifier">MESH:C565377</infon><infon key="type">Disease</infon><location length="19" offset="2016"/><text>aeruginosa isolates</text></annotation><annotation id="23"><infon key="Identifier">MESH:D007239</infon><infon key="type">Disease</infon><location length="9" offset="2056"/><text>infection</text></annotation></passage></document><document><id>31106078</id><passage><infon key="journal">Cureus; 2019 Mar 051 1113) 4178. doi:10.7759/cureus.4178</infon><infon key="year">2019</infon><infon key="article-id_pmc">PMC6504024</infon><infon key="type">title</infon><infon key="authors">Inayat F, Azam S, Baig AS, Nawaz G, Ullah W, </infon><offset>0</offset><text>Presentation Patterns, Diagnostic Modalities, Management Strategies, and Clinical Outcomes in Patients with Hydatid Disease of the Pelvic Bone: A Comparative Review of 31 Cases.</text><annotation id="1"><infon key="identifier">9606</infon><infon key="type">Species</infon><location length="8" offset="94"/><text>Patients</text></annotation></passage><passage><infon key="type">abstract</infon><offset>178</offset><text>Hydatid disease is a parasitic zoonosis commonly caused by Echinococcus granulosus. It characteristically involves the liver and the lungs but rare occurrences in other organs have also been reported. Bone involvement is distinctly uncommon, which is predominantly a silent and slowly progressive disease with a long latent period. We conducted a systematic literature search of MEDLINE, Cochrane, Embase, and Scopus databases. After a comprehensive review of the search results, a total of 31 cases of hydatid disease of the pelvic bone fulfilled the inclusion criteria. The data on patient demographics, epidemiology, lesion site, management, clinical outcomes, and follow-up were collected and analyzed. This review illustrates that hydatid disease should be considered among the differential diagnoses of unusual cystic lesions of the pelvic bone. Prompt diagnosis and appropriate management are of paramount importance to prevent bone destruction and serious complications in these patients. Long-term follow-up should be performed for potential recurrence.</text><annotation id="7"><infon key="Identifier">MESH:D004443</infon><infon key="type">Disease</infon><location length="15" offset="178"/><text>Hydatid disease</text></annotation><annotation id="8"><infon key="Identifier">MESH:D010272</infon><infon key="type">Disease</infon><location length="18" offset="199"/><text>parasitic zoonosis</text></annotation><annotation id="9"><infon key="identifier">6210</infon><infon key="type">Species</infon><location length="23" offset="237"/><text>Echinococcus granulosus</text></annotation><annotation id="10"><infon key="identifier">9606</infon><infon key="type">Species</infon><location length="7" offset="762"/><text>patient</text></annotation><annotation id="11"><infon key="identifier">9606</infon><infon key="type">Species</infon><location length="8" offset="1165"/><text>patients</text></annotation></passage></document><document><id>31106528</id><passage><infon key="journal">Pediatr. Pulmonol.; 2019 May 201 doi:10.1002/ppul.24361</infon><infon key="year">2019</infon><infon key="type">title</infon><infon key="authors">Savant AP, McColley SA, </infon><offset>0</offset><text>Cystic fibrosis year in review 2018, part 1.</text><annotation id="1"><infon key="Identifier">MESH:D003550</infon><infon key="type">Disease</infon><location length="15" offset="0"/><text>Cystic fibrosis</text></annotation></passage><passage><infon key="type">abstract</infon><offset>45</offset><text>Cystic fibrosis research and case reports were robust in the year 2018. This report summarizes research and cases related to Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulator therapies, inflammation and infection, epidemiology and the physiologic, and imaging assessment of disease.</text><annotation id="6"><infon key="Identifier">MESH:D003550</infon><infon key="type">Disease</infon><location length="15" offset="45"/><text>Cystic fibrosis</text></annotation><annotation id="7"><infon key="identifier">1080</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">55465</infon><location length="51" offset="170"/><text>Cystic Fibrosis Transmembrane Conductance Regulator</text></annotation><annotation id="8"><infon key="identifier">1080</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">55465</infon><location length="4" offset="223"/><text>CFTR</text></annotation><annotation id="9"><infon key="Identifier">MESH:D007249</infon><infon key="type">Disease</infon><location length="26" offset="250"/><text>inflammation and infection</text></annotation></passage></document><document><id>31106941</id><passage><infon key="journal">J. Obstet. Gynaecol. Res.; 2019 May 201 doi:10.1111/jog.13999</infon><infon key="year">2019</infon><infon key="type">title</infon><infon key="authors">Maeda Y, Uematsu K, Matsubayashi A, Yoshioka S, </infon><offset>0</offset><text>Pulse granuloma presenting as a complex pelvic cyst.</text><annotation id="1"><infon key="Identifier">MESH:D006099</infon><infon key="type">Disease</infon><location length="9" offset="6"/><text>granuloma</text></annotation></passage><passage><infon key="type">abstract</infon><offset>53</offset><text>Pulse granuloma, a benign granulomatous lesion, develops due to foreign body reactions to food particles. This rare entity occurs occasionally in the abdominal cavity. However, it has never been reported as a pelvic mass or a recurrent case. A 37-year-old woman with a medical history of pelvic granulomatous lesions treated in Thailand, was admitted for abdominal pain. Imaging study revealed a pelvic complex cyst and disseminated nodules. Ovarian cancer or tuberculous peritonitis was suspected. The appearance at laparotomy was an inflammatory mass encased in adhesions; therefore, only biopsy was performed. The pathology diagnosis was pulse granuloma. The pathology report from Thailand was obtained only after her discharge, suggesting that the previous granulomatous lesion contained vegetable matter. This report demonstrates that pulse granuloma can present as a pelvic mass and may relapse. For complex cystic lesions with solid components in the pelvis, pulse granuloma should be considered as a differential diagnosis.</text><annotation id="14"><infon key="Identifier">MESH:D006099</infon><infon key="type">Disease</infon><location length="9" offset="59"/><text>granuloma</text></annotation><annotation id="15"><infon key="Identifier">MESH:D006105</infon><infon key="type">Disease</infon><location length="20" offset="79"/><text>granulomatous lesion</text></annotation><annotation id="16"><infon key="identifier">9606</infon><infon key="type">Species</infon><location length="5" offset="309"/><text>woman</text></annotation><annotation id="17"><infon key="Identifier">MESH:D034161</infon><infon key="type">Disease</infon><location length="28" offset="341"/><text>pelvic granulomatous lesions</text></annotation><annotation id="18"><infon key="Identifier">MESH:D015746</infon><infon key="type">Disease</infon><location length="14" offset="408"/><text>abdominal pain</text></annotation><annotation id="19"><infon key="Identifier">MESH:D010051</infon><infon key="type">Disease</infon><location length="14" offset="495"/><text>Ovarian cancer</text></annotation><annotation id="20"><infon key="Identifier">MESH:D014395</infon><infon key="type">Disease</infon><location length="23" offset="513"/><text>tuberculous peritonitis</text></annotation><annotation id="21"><infon key="Identifier">MESH:D006099</infon><infon key="type">Disease</infon><location length="9" offset="700"/><text>granuloma</text></annotation><annotation id="22"><infon key="Identifier">MESH:D006105</infon><infon key="type">Disease</infon><location length="20" offset="814"/><text>granulomatous lesion</text></annotation><annotation id="23"><infon key="Identifier">MESH:D006099</infon><infon key="type">Disease</infon><location length="9" offset="899"/><text>granuloma</text></annotation><annotation id="24"><infon key="Identifier">MESH:D052177</infon><infon key="type">Disease</infon><location length="14" offset="967"/><text>cystic lesions</text></annotation><annotation id="25"><infon key="Identifier">MESH:D006099</infon><infon key="type">Disease</infon><location length="9" offset="1025"/><text>granuloma</text></annotation></passage></document><document><id>31107040</id><passage><infon key="journal">Monaldi Arch Chest Dis; 2019 May 201 8912)1 doi:10.4081/monaldi.2019.1035</infon><infon key="year">2019</infon><infon key="type">title</infon><infon key="authors">Vizzardi E, Sciatti E, Bonadei I, Cani DS, Menotti E, Prati F, Dallapellegrina L, Metra M, Berlendis M, Poli P, Padoan R, </infon><offset>0</offset><text>Macro- and microvascular functions in cystic fibrosis adults without cardiovascular risk factors: A case-control study.</text><annotation id="1"><infon key="Identifier">MESH:D003550</infon><infon key="type">Disease</infon><location length="15" offset="38"/><text>cystic fibrosis</text></annotation></passage><passage><infon key="type">abstract</infon><offset>120</offset><text>Increasing survival from cystic fibrosis show untypical systems involvement, such as cardiocirculatory. In particular, the presence of CFTR in smooth muscle and endothelial cells, systemic inflammation and oxidative stress could explain vascular alterations in these patients. We aimed at noninvasely evaluating macro- and microvascular dysfunction in cystic fibrosis adults without cardiovascular risk factors. Twenty-twoadults affected by cystic fibrosis and 24 healthy volunteers matched for age and sex were enrolled. None had known cardiovascular risk factors. All people underwent blood pressure measurement, microvascular function assessment by EndoPAT-2000 device (calculating RH-PAT index) and macrovascular evaluation by pulse wave velocity (PWV). RH-PAT index was significantly lower in patients than in controls (1.74+-0.59 vs 2.33+-0.34; p&amp;lt;0.001). Thirteen patients of 22 had a value inferior to the threshold of 1.67 (59.1%), while no controls had (p&amp;lt;0.001). Carotid-femoral PWV did not differ between the two groups (5.2+-1.5 m/s vs 5.4+-1.1; p=0.9), while brachial-ankle one did (11.0+-2.2 m/s vs 10.1+-0.8 m/s; p=0.04).Adults patients affected by cystic fibrosis show peripheral endothelial dysfunction, which is the first alteration in atherosclerotic phenomenon. Moreover, arterial stiffness measured by PWV unclearly seems to differ respect of healthy people, perhaps because PWV alterations are typical of above 50 years old people. It is unclear what prognostic role of future developing of atherosclerotic disease these findings could be, but it seems evident that cystic fibrosis directly affects cardiovascular system itself.</text><annotation id="23"><infon key="Identifier">MESH:D003550</infon><infon key="type">Disease</infon><location length="15" offset="145"/><text>cystic fibrosis</text></annotation><annotation id="24"><infon key="identifier">1080</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">55465</infon><location length="4" offset="255"/><text>CFTR</text></annotation><annotation id="25"><infon key="Identifier">MESH:D007249</infon><infon key="type">Disease</infon><location length="12" offset="309"/><text>inflammation</text></annotation><annotation id="26"><infon key="identifier">9606</infon><infon key="type">Species</infon><location length="8" offset="387"/><text>patients</text></annotation><annotation id="27"><infon key="Identifier">MESH:D017566</infon><infon key="type">Disease</infon><location length="25" offset="443"/><text>microvascular dysfunction</text></annotation><annotation id="28"><infon key="Identifier">MESH:D003550</infon><infon key="type">Disease</infon><location length="15" offset="472"/><text>cystic fibrosis</text></annotation><annotation id="29"><infon key="Identifier">MESH:D003550</infon><infon key="type">Disease</infon><location length="15" offset="561"/><text>cystic fibrosis</text></annotation><annotation id="30"><infon key="identifier">9606</infon><infon key="type">Species</infon><location length="6" offset="690"/><text>people</text></annotation><annotation id="31"><infon key="identifier">31732</infon><infon key="type">Species</infon><location length="3" offset="872"/><text>PWV</text></annotation><annotation id="32"><infon key="identifier">9606</infon><infon key="type">Species</infon><location length="8" offset="918"/><text>patients</text></annotation><annotation id="33"><infon key="identifier">9606</infon><infon key="type">Species</infon><location length="8" offset="993"/><text>patients</text></annotation><annotation id="34"><infon key="identifier">31732</infon><infon key="type">Species</infon><location length="3" offset="1115"/><text>PWV</text></annotation><annotation id="35"><infon key="identifier">9606</infon><infon key="type">Species</infon><location length="8" offset="1269"/><text>patients</text></annotation><annotation id="36"><infon key="Identifier">MESH:D003550</infon><infon key="type">Disease</infon><location length="15" offset="1290"/><text>cystic fibrosis</text></annotation><annotation id="37"><infon key="Identifier">MESH:D050197</infon><infon key="type">Disease</infon><location length="15" offset="1380"/><text>atherosclerotic</text></annotation><annotation id="38"><infon key="identifier">31732</infon><infon key="type">Species</infon><location length="3" offset="1449"/><text>PWV</text></annotation><annotation id="39"><infon key="identifier">9606</infon><infon key="type">Species</infon><location length="6" offset="1498"/><text>people</text></annotation><annotation id="40"><infon key="identifier">31732</infon><infon key="type">Species</infon><location length="3" offset="1522"/><text>PWV</text></annotation><annotation id="41"><infon key="identifier">9606</infon><infon key="type">Species</infon><location length="6" offset="1572"/><text>people</text></annotation><annotation id="42"><infon key="Identifier">MESH:D050197</infon><infon key="type">Disease</infon><location length="23" offset="1639"/><text>atherosclerotic disease</text></annotation><annotation id="43"><infon key="Identifier">MESH:D003550</infon><infon key="type">Disease</infon><location length="15" offset="1714"/><text>cystic fibrosis</text></annotation></passage></document><document><id>31107204</id><passage><infon key="journal">J. Med. Microbiol.; 2019 May 201 doi:10.1099/jmm.0.001001</infon><infon key="year">2019</infon><infon key="type">title</infon><infon key="authors">Zhan SH, French L, </infon><offset>0</offset><text>Sequence similarity searches for morphine biosynthesis enzymes in bacteria yield putative targets for understanding associations between infection and opiate administration.</text><annotation id="3"><infon key="Identifier">MESH:D009020</infon><infon key="type">Chemical</infon><location length="8" offset="33"/><text>morphine</text></annotation><annotation id="4"><infon key="identifier">2</infon><infon key="type">Species</infon><location length="8" offset="66"/><text>bacteria</text></annotation><annotation id="5"><infon key="Identifier">MESH:D007239</infon><infon key="type">Disease</infon><location length="9" offset="137"/><text>infection</text></annotation></passage><passage><infon key="type">abstract</infon><offset>174</offset><text>Exploiting the immunosuppressive, analgesic and highly addictive properties of morphine could increase the success of a bacterial pathogen. Therefore, we performed sequence similarity searches for two morphine biosynthesis demethylases in bacteria. For thebaine 6-O-demethylase and codeine O-demethylase, we found strong alignments to three (Pseudomonas aeruginosa, Klebsiella pneumoniae and Acinetobacter baumannii) of the six ESKAPE pathogens (Enterococcus faecalis, Staphylococcus aureus, K. pneumoniae, A. baumannii, P. aeruginosa and Enterobacter species) that are commonly associated with drug resistance and nosocomial infections. Expression of the aligned sequence found in P. aeruginosa (NP_252880.1/PA4191) is upregulated in isolates obtained from cystic fibrosis patients. Our findings provide putative mechanistic targets for understanding the role of morphine in pathogenicity.</text><annotation id="24"><infon key="Identifier">MESH:D009020</infon><infon key="type">Chemical</infon><location length="8" offset="253"/><text>morphine</text></annotation><annotation id="25"><infon key="identifier">2</infon><infon key="type">Species</infon><location length="9" offset="294"/><text>bacterial</text></annotation><annotation id="26"><infon key="Identifier">MESH:D009020</infon><infon key="type">Chemical</infon><location length="8" offset="375"/><text>morphine</text></annotation><annotation id="27"><infon key="identifier">2</infon><infon key="type">Species</infon><location length="8" offset="413"/><text>bacteria</text></annotation><annotation id="28"><infon key="Identifier">MESH:D013797</infon><infon key="type">Chemical</infon><location length="8" offset="427"/><text>thebaine</text></annotation><annotation id="29"><infon key="Identifier">MESH:D013481</infon><infon key="type">Chemical</infon><location length="3" offset="436"/><text>6-O</text></annotation><annotation id="30"><infon key="Identifier">MESH:D003061</infon><infon key="type">Chemical</infon><location length="9" offset="456"/><text>codeine O</text></annotation><annotation id="31"><infon key="identifier">573</infon><infon key="type">Species</infon><location length="21" offset="540"/><text>Klebsiella pneumoniae</text></annotation><annotation id="32"><infon key="identifier">470</infon><infon key="type">Species</infon><location length="23" offset="566"/><text>Acinetobacter baumannii</text></annotation><annotation id="33"><infon key="identifier">1351</infon><infon key="type">Species</infon><location length="21" offset="620"/><text>Enterococcus faecalis</text></annotation><annotation id="34"><infon key="identifier">1280</infon><infon key="type">Species</infon><location length="21" offset="643"/><text>Staphylococcus aureus</text></annotation><annotation id="35"><infon key="identifier">573</infon><infon key="type">Species</infon><location length="13" offset="666"/><text>K. pneumoniae</text></annotation><annotation id="36"><infon key="identifier">287</infon><infon key="type">Species</infon><location length="13" offset="695"/><text>P. aeruginosa</text></annotation><annotation id="37"><infon key="Identifier">MESH:D003428</infon><infon key="type">Disease</infon><location length="21" offset="789"/><text>nosocomial infections</text></annotation><annotation id="38"><infon key="identifier">287</infon><infon key="type">Species</infon><location length="13" offset="856"/><text>P. aeruginosa</text></annotation><annotation id="39"><infon key="Identifier">MESH:D003550</infon><infon key="type">Disease</infon><location length="15" offset="932"/><text>cystic fibrosis</text></annotation><annotation id="40"><infon key="identifier">9606</infon><infon key="type">Species</infon><location length="8" offset="948"/><text>patients</text></annotation><annotation id="41"><infon key="Identifier">MESH:D009020</infon><infon key="type">Chemical</infon><location length="8" offset="1038"/><text>morphine</text></annotation></passage></document></collection>
